Arix Bioscience Share Discussion Threads

[rambutan2] 01/10/2020 21:53

It's a raising not an IPO. It listed 2yrs ago, at $10.

[bahiflyer] 01/10/2020 21:22

Looking brighter with some traction behind ARIX now Woodford well and truly gone and now another NASDAQ IPO with LogicBio. Should see the gap to NAV continue to close

[escapetohome] 18/9/2020 18:29

A very very welcome day!
NICE.

[roger148] 08/9/2020 15:29

I bought a few this am but now sold out.

[eaaxs06] 08/9/2020 11:29

Cracking results and a very positive statement for the future, which has been taken well by the market.

Let's hope we see a bit more positive interest from across the pond, when their markets open this afternoon.

Good luck everyone, Sid.

[escapetohome] 08/9/2020 10:33

It would seem so norbie.

Great update. Really positive for the future.

Im glad i found this share.

Im in profit and holding.

[ohisay] 08/9/2020 10:04

Presentations ...and webcast at 1230 if anybody's interested .

Nav of 185p suggests overlarge disconnect with the share price especially with 32p per share cash on the balance sheet..I've added this morning .

[n0rbie] 08/9/2020 08:32

So they are trading at over 50% discount to NAV

[escapetohome] 08/9/2020 08:04

Dr Naseem Amin, Executive Chairman of Arix Bioscience plc, commented:

"This has been a pivotal period for Arix and our companies. We have refocused and streamlined the business, significantly reducing costs in order to maximise returns for our shareholders. Over the period our portfolio has continued to make strong progress, with a number of companies reaching important clinical milestones and completing additional financing rounds at higher valuations.

[escapetohome] 08/9/2020 08:00

Net Asset Value of £251.0 million (December 2019: £202.1 million); 185p per share (December 2019: 149p); a 24% increase for the first six months of 2020 Net positive portfolio revaluation of £51.7 million[1] in the period Gross Portfolio Value of £203.4 million (December 2019: £149.2 million) £11.6 million of capital deployed into the portfolio during the period £9.1 million of capital realised during the period Cash of £44.0 million (December 2019: £54.6 million) 20% IRR generated by the Gross Portfolio since inception in 2016
---[1] Including FXOperational and strategic progress:

[cokehookerscars] 02/9/2020 12:05

SYNC is very interesting but whilst similar in some ways, each of these types of companies are quite different based upon their very specific holdings and the pipelines of those specific companies.

ARIX seem to have a few more irons in the fire than SYNC so I still have high hopes for ARIX but we need to see more positive news coming out in order to have confidence things are going the right way for those things in the pipelines.

[cokehookerscars] 02/9/2020 12:01

Pleased my under 60 expectation didn't materialise. Surprised. Happy days.
If we do see sub 60 with a general drop of the stock market I may well top up but we need to start seeing some better news to give confidence that this will bear fruit in the future (5-10 years).

No doubt Woodford's interest didn't help this, but they need to show developments are moving in a very positive way if they are to start to shrug off the current downward trend.

[escapetohome] 02/9/2020 09:43

Took a nibble at these.
A comparable outfit seems to be Syncona (SYNC) , but where that seems to have done quite well and perhaps even trades at a premium, i sense ARix trades at a heavy discount and has performed poorly.

Why? Woodfords spell? They both seem to own Autolus.

Might have to wait a while before they perk up.

[cokehookerscars] 31/7/2020 14:25

Looking a bit sad :-(
Back to under 60 next week :-(

[rambutan2] 12/6/2020 15:00

ARIX is one of the 19:

Acacia Research Corporation ("we", "Acacia" or "the Company") (Nasdaq: ACTG), a publicly-traded investor in absolute return assets, today announced that it had entered into an agreement with Link Fund Solutions Limited ("LFS") to purchase shares in up to 19 public and private life sciences companies from LF Equity Income Fund (the "Fund") for a total consideration of up to £223.9 million. The acquisition of the private companies is subject to the waiver or completion of customary pre-emption processes of such companies...





Acacia is backed by well known activist hedge fund

[hashertu] 08/6/2020 11:13

What does "a" managing director do?
I must confess to being confused about who does what.

[eaaxs06] 27/5/2020 15:59

Looks like it's moving day; nice to see.

Hopefully we can see more of the same tomorrow.

[semaj2000] 20/5/2020 10:44

Arix’s Amplyx Pharmaceuticals secures over $90m in funding -

[cokehookerscars] 28/4/2020 11:38

It does, although more detail would have been nice :-)

It was 200p at 31st Dec 2018.
Was 149p at 31st Dec 2019.

[saul goodman] 21/4/2020 11:23

No. I hope that helps.